Health Canada drug identification number

DIN 02240749 — SUPREFACT DEPOT 3 MONTHS 9.45 MG

SUPREFACT DEPOT 3 MONTHS is a implant of Buserelin marketed by CHEPLAPHARM ARZNEIMITTEL GMBH. The full Buserelin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02240749
Brand name
SUPREFACT DEPOT 3 MONTHS
Active ingredient
Buserelin
Strength
9.45 MG
Dosage form
IMPLANT
Route
SUBCUTANEOUS
Manufacturer
CHEPLAPHARM ARZNEIMITTEL GMBH
Health Canada status
DORMANT
Drug class
Gonadotropin-releasing hormone (GnRH/LHRH) agonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Buserelin products

DINBrandStrengthFormManufacturerStatus
02225166 SUPREFACT 1 MG SOLUTION CHEPLAPHARM ARZNEIMITTEL GMBH MARKETED
02228955 SUPREFACT DEPOT 2 MONTHS 6.3 MG IMPLANT CHEPLAPHARM ARZNEIMITTEL GMBH DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.